Perafensine
Perafensine (INN) (code name HR-459) is a drug which was investigated as an antidepressant but was never marketed.[1] It has been reported to antagonize the effects of reserpine and to inhibit the reuptake of norepinephrine (norepinephrine reuptake inhibitor); whether it also affects the reuptake of serotonin or dopamine is unclear.[2]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H19N3 |
Molar mass | 289.382 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
References
- C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1585–. ISBN 978-0-412-46630-4.
- Bondinell, WilliamE.; Kaiser, Carl (1982). "Chapter 5. Antidepressants". 17: 41–50. doi:10.1016/S0065-7743(08)60487-X. ISSN 0065-7743. Cite journal requires
|journal=
(help)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.